CVIMP

Creating Memory: Vaccines & Immunity

Who are vaccinologists and what do they do? Hear from scientists working to develop new vaccines and understand immunity to microbial pathogens.

Husk at besøge podcastens hjemmeside og støtte skaberen: CVIMP.podbean.com

Forfatter

CVIMP

Kategori

Science

Podcastens hjemmeside

CVIMP.podbean.com

Seneste episode

10. nov. 2026

Hvor kan du lytte?

Podcasts i appen Replaio Radio Kommer snart

Podcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts

Hent den på Google Play Installer gratis Android 10 mio.+ downloads · 4,7+ i bedømmelse iOS snart

Episoder

Episode 38: Using non-human primates to understand how to develop more effective TB vaccines 10.11.2026

We talk with Dr. JoAnne Flynn, Professor and Chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine, who uses non-human primate models of Mycobacterium tuberculosis (Mtb) to determine who are the 'players' in the protective immune response for TB. 

Episode 37: How to get AHEAD of the next epidemic 10.11.2026

We talk with Dr. James Crowe, Director of the Vanderbilt Center for Antibody Therapeutics and Professor of Pediatrics, Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center, who seeks to discover, manufacture and stockpile highly potent monoclonal antibodies ahead of the next epidemic.

Episode 36: Optimizing monoclonal antibody therapeutics for bacterial pathogens 10.11.2026

We talk with Dr. Antonio DiGiandomenico, Senior Director and Head of Microbial Antibodies and Technologies within AstraZeneca’s early Infectious Disease unit, who uses new delivery modalities to enhance monoclonal antibody therapeutics for bacterial pathogens such as Pseudomonas aeruginosa.

Episode 35: Studying parasites and mRNA vaccines to understand protective immunity 09.11.2026

We talk with Dr. Christopher Hunter, Professor and Director of the Institute for Infectious & Zoonotic Diseases in the University of Pennsylvania School of Veterinary Medicine in Philadelphia, PA, who studies the initiation of immunity by parasites and mRNA vaccines to inform new vaccine development.

Episode 34: Developing new systems to evaluate vaccines for diarrheal diseases 09.11.2026

We talk with Dr. Gagandeep Kang, Director - Enterics, Diagnotics, Genomics & Epidemiology at the Gates Foundation, who leads efforts to understand and develop vaccines for rotavirus, cholera, typhoid and shigella.

Episode 33: Using mathematical modeling to understand determinants of dengue virus pathogenecity and immunity 31.10.2026

We talk with Dr. Rosemary Aogo, a postdoctoral research fellow at the National Institute of Health, MD, who uses mathematical and computational modeling of experimental, clinical and cohort data to inform next generation flavivirus vaccines and therapeutics.

Episode 32: Understanding fundamental mechanisms of B cell function 05.10.2026

We talk with Dr. Chris Risley, a postdoctoral fellow at the University of Alabama at Birmingham, AL, who studies the regulation of local B cell responses in airway tissues and its role in protective immunity.

Episode 31: Understanding determinants of T cell responses following respiratory virus infection and vaccination 25.08.2026

We talk with Dr. Mark Painter, a postdoctoral fellow at the University of Pennsylvania Perelman School of Medicine, PA, who studies the role of T cells following respiratory virus infection or vaccination as well as in immune memory, cancer, aging and autoimmunity.

Episode 30: Using deep mutational scanning to characterize interactions between influenza and MHC-II 03.08.2026

We talk with Dr. Bernadeta Dadonaite, a research associate  at the Fred Hutchinson Cancer Center, WA, who studies interactions between the influenza attachment protein hemagglutinin and its newly identified receptor protein, MHC-II.

Episode 29: Use of structural approaches to develop 'universal' influenza vaccines 06.07.2026

We talk with Dr. Julianna Han, a senior staff scientist at the Scripps Research institute, CA, who studies antibody-epitope interactions following human influenza virus infection and vaccination to inform the development of novel influenza immunogens and antibody therapeutics. 

Episode 28: The importance of primate models to understand CMV vaccine vectors 26.05.2026

We talk with Dr. Daniel Malouli, an assistant professor at the Vaccine and Gene Therapy Institute at the Oregon Health and Science University, OR, who studies how virus-host interactions modulate CMV infection and pathogenesis as well as determine the safety and efficacy of CMV-based vaccine vectors.  

Episode 27: IRGM1 regulation of host immunity during vaccination 28.04.2026

We talk with Dr. Sumanta Naik, a staff scientist in the Department of Molecular Microbiology at Washington University School of Medicine, who is investigating the role of IRGM1 in type I interferon and B cell responses following vaccination and tuberculosis infection. 

Episode 26: Harnessing bacterial components for vaccines and therapeutics 08.04.2026

We talk with Dr. Mario Feldman, Professor of Microbiology at Washington University School of Medicine in St. Louis, MO who studies the pathogenesis of Acinetobacter and the biogenesis of bacterial extracellular vesicles.

Episode 25: Understanding the role of T cells to improve vaccination for respiratory pathogens 08.04.2026

We talk with Dr. Daniel Hoft, Director of the Division of Infectious Diseases, Allergy & Immunology and the Center for Vaccine Development at Saint Louis University School of Medicine in St. Louis, MO who studies the development of T-cell targeting vaccines against mucosally-invasive intracellular pathogens such as tuberculosis and influenza.

Episode 24: Understanding Tfh cells to improve vaccine-induced antibody responses 08.04.2026

We talk with Dr. Michela Locci, Associate Professor of Microbiology at the University of Pennsylvania Perelman School of Medicine in Philadelphia, PA who studies how T follicular helper cells promote optimal germinal cell reactions and antibody responses following vaccination.

Episode 23: Developing novel lipid nanoparticles to improve vaccine-induced immune responses 27.03.2026

We talk with Dr. Namit Chaudhary, a postdoctoral researcher in the Department of Immunology & Microbiology at The Scripps Research Institute, CA, who develops new technologies to generate a safe and effective single-shot lipid nanoparticle-based HIV vaccine. 

Episode 22: Use of VSV-chimeras to understand emerging virus infection and develop anti-viral countermeasures 06.03.2026

We talk with Dr. Zhouming Liu, an assistant professor of Molecular Microbiology at Washington University School of Medicine, MO, who studies mechanisms of La Cross virus entry and monoclonal antibody–mediated inhibition of infection.

Episode 21: A role for T cells in flavivirus vaccination and pathogenesis 27.01.2026

We talk with Dr. Annie Elong Ngono, a research instructor in the Center for Vaccine Innovation at the La Jolla Institute for Immunology, CA, who studies the role of T cells in vaccine-mediated protection and neurological disease following flavivirus infection.

Episode 20: Understanding broadly protective immune responses to develop pandemic virus vaccines 19.12.2025

We talk with Dr. Anass Abbad, a postdoctoral fellow in the Department of Microbiology at the Icahn School of Medicine Mount Sinai, NY who studies humoral immune responses and virus-host receptor interactions to design next generation pandemic virus vaccines.

Episode 19: Using structural immunology to understand protective or pathogenic antibodies 23.11.2025

We talk with Dr. Sandhya Bangaru, a staff scientist in the Department of Integrative Structural and Computational Biology at The Scripps Research Institute, CA who uses advances in cryo-EM to understand antibody epitopes important for their antiviral protective activity and their pathogenic activity in allergic diseases.

Episode 18: Understanding B cell responses to natural infection to design better vaccines 31.10.2025

We talk with Dr. Florian Krammer, the endowed Mount Sinai Professor of Vaccinology at the Icahn School of Medicine, New York, NY and Director of the Ludwig Boltzmann Institute for Science Communication and Pandemic Preparedness at the Medical University of Vienna, Austria, who studies the B cell response in the context of natural infection to better understand how to design broadly protective and...

Episode 17: Using a rodent hepacivirus to uncover a role for iHALT during HCV infection 28.10.2025

We talk with Dr. John Gridley, a postdoctoral fellow in the Vaccinology Training Program at Emory University, GA, who uses a hepatitis C virus-related rodent hepacivirus model to identify correlates of protective immunity for HCV and the role of inducible Hepatic-Associated Lymphoid Tissue (iHALT) in the induction of this immune response.

Episode 16: Creating healthy local communities to foster local to global impact 08.10.2025

We talk with Dr. Sandro Galea, Dean and Professor of the School of Public Health at Washington University in St. Louis, who uses population based sciences to promote health locally and globally.

Episode 15: Understanding B cell immune responses and memory to guide vaccine design 07.10.2025

We talk with Dr. Hedda Wardemann, Division Head of B Cell Immunology at the German Cancer Research Center and Professor at the Medical Faculty of the University of Heidelberg in Heidelberg, Germany, who studies B cell responses in the context of infectious disease and cancer. . 

Episode 14: Using Reverse Vaccinology 3.0 for Pandemic Preparedness 03.10.2025

We talk with Dr. Emanuele Andreano, Head of Serology and Immunology at Fondazione Biotecnopolo di Siena, Italy, who combines immunology, structural biology and artificial intelligence to rapidly develop novel monoclonal antibodies therapies and antiviral vaccine targets.

Lyt til podcasten Creating Memory: Vaccines & Immunity i Replaio

Radio og podcasts i én app - gratis og uden tilmelding. Installer i dag, og gå ikke glip af lanceringen

Hent den på Google Play

Replaio er ikke podcastudgiver; programmernes navne, coverbilleder og lyd tilhører deres ophavsmænd og distribueres via offentlige RSS-feeds.